Quantcast

Latest Thrombolysis Stories

2014-08-08 10:47:23

The Lancet Reduces long-term disability, even in older people and in those with the most severe stroke Many more stroke patients could benefit from thrombolytic treatment (the use of drugs to break up or dissolve blood clots), but it needs to be administered as quickly as possible after the first signs of illness, according to new findings from the largest meta-analysis to date investigating the clot-busting drug alteplase. The study, which involved more than 6700 stroke patients, is...

2014-07-03 20:21:28

At the California Institute for Deep Venous Thrombosis, Dr. Malekmehr and his team perform thrombolysis, mechanical thrombectomy and many other cutting-edge treatments for sufferers of DVT LOS ANGELES, July 3, 2014 /PRNewswire/ -- Each year, deep vein thrombosis (DVT) leads to hospitalization for approximately 250,000 Americans, and often leads to serious - and even fatal - complications. Fortunately, at the California Institute for Deep Venous Thrombosis, those suffering from the...

2014-06-19 09:32:37

The JAMA Network Journals In an analysis that included data from 16 trials performed over the last 45 years, among patients with pulmonary embolism, receipt of therapy to dissolve the blood clot (thrombolysis) was associated with lower rates of death, but increased risks of major bleeding and intracranial hemorrhage, according to a study in the June 18 issue of JAMA. The authors note that these findings may not apply to patients with low-risk pulmonary embolism. Pulmonary embolism (PE;...

2014-06-18 12:16:58

University of Pennsylvania School of Medicine Adding thrombolysis drugs to conventional therapy may offer significant benefits in select patients Bringing clarity to a decades-long debate, a national team of researchers led by experts from the Perelman School of Medicine at the University of Pennsylvania has found that adding clot-busting medications known as thrombolytics to conventional approaches when treating sudden-onset pulmonary embolism patients is associated with 47 percent...

2014-06-02 08:30:20

REHOVOT, Israel, June 2, 2014 /PRNewswire/ -- D-Pharm Ltd. (TASE: DPRM), Rehovot, Israel, reports today, June 2nd, 2014, the interim results for the second dose tier of stroke patients that completed follow-up in its Phase 2 clinical study of THR-18 and confirms the tolerability of THR-18 at a dose of 0.54 mg/kg, administered together with tissue plasminogen activator (tPA) in acute ischemic stroke (AIS) patients. The primary goal of the current study is to identify the...

2014-05-21 12:08:36

EuroPCR Optimizing treatment strategies is dependent on resources and geography A Great Debate at EuroPCR 2014 saw experts discussing the role of the two most valuable strategies to save the lives of ST-segment Elevation Myocardial Infarction (STEMI) patients: primary percutaneous coronary intervention (PCI) and thrombolysis. Both these are effective treatments that actively save lives, and when there is no option for primary percutaneous coronary intervention, thrombolysis is the...

2014-04-24 23:09:00

UVA's stroke program has received the highest quality award from the American Heart Association. Charlottesville,VA (PRWEB) April 24, 2014 The American Heart Association has recognized the quality and safety of UVA’s stroke care with two awards. UVA received both the Get With The Guidelines®-Stroke Gold-Plus Quality Achievement Award and made the Target: Stroke Honor Roll. The awards represent the highest level of stroke quality recognition offered by the AHA. “We couldn’t...

2014-04-23 09:46:08

Study finds jump in patients receiving clot-busting drug within 'golden hour' Administering a clot-dissolving drug to stroke victims quickly — ideally within the first 60 minutes after they arrive at a hospital emergency room — is crucial to saving their lives, preserving their brain function and reducing disability. Given intravenously, tPA (tissue plasminogen activator) is currently the only Food and Drug Administration–approved therapy shown to improve outcomes for patients...

2014-04-23 09:40:01

Using an ambulance that included a computed tomography (CT) scanner, point-of-care laboratory, telemedicine connection and a specialized prehospital stroke team resulted in decreased time to treatment for ischemic stroke, according to a study in the April 23/30 issue of JAMA, a neurology theme issue. Stroke is a leading cause of death and disability. In acute ischemic stroke, thrombolysis (dissolving of blood clots) using intravenous tissue plasminogen activator (tPA) is the treatment of...

2014-04-23 09:38:28

The majority of adults surveyed indicated they would want administration of clot-dissolving medications if incapacitated by a stroke, a finding that supports clinicians' use of this treatment if patient surrogates are not available to provide consent, according to a study in the April 23/30 issue of JAMA, a neurology theme issue. "In life-threatening emergencies involving incapacitated patients without surrogates, clinicians may intervene without obtaining informed consent, applying the...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.